Kriengkrai Prasert

4PUBLICATIONS
15CO-AUTHORS
Major global burdens of diseaseApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nanotoxicology, health and safetyEpidemiology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 26, 2026
Influenza Vaccine Effectiveness Against Pneumonia and COPD Exacerbations Among Patients with Chronic Obstructive Pulmonary Disease in Thailand: A National Test-Negative Design Study, 2013-2024.

|Aug 26, 2026
Safety and Immunogenicity of an Additional Dose of Thailand Government Pharmaceutical Organization (GPO) Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Administered After Primary Vaccination with HXP-GPOVac or BNT162b2: An Open-Label Phase II Extension Trial in Thai Adults.

|Jun 25, 2026
Safety and Immunogenicity of a Locally Produced Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Compared with BNT162b2: A Phase II Randomized, Controlled, Double-Blind Noninferiority Trial in Thai Adults.

|May 30, 2026
Risk of Hospitalization Related to Influenza A(H3N2) Virus Subclade K, Thailand, June-December 2025.

Pageof 1

Frequent Collaborators

3 joint publications

Sutthichai Nakphook

2 joint publications

Jiraphut Kittiwatanachod

2 joint publications

Bruce L Innis

2 joint publications

Somchaiya Surichan